Acetylcholine content of and release from isolated pelviureteral tract.
Measurements were taken for the acetylcholine content of animal and human pelviureteral muscle and for the release of acetylcholine at rest and during field stimulation of the isolated renal pelvis and ureter. Release was frequency-dependent, with the maximum output obtained at 10 Hz. The release of acetylcholine from reserpine-pretreated and piperoxan-treated tissues remained unchanged, but tetrodotoxin (1.10(-6) g/ml) and noradrenaline (2.10(-6) g/ml) significantly reduced the output.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D004558:Electric Stimulation; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007682:Kidney Pelvis / Q000378:metabolism*; D009130:Muscle, Smooth / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D010883:Piperoxan / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D013045:Species Specificity; D013779:Tetrodotoxin / Q000494:pharmacology; D014513:Ureter / Q000187:drug effects / Q000378:metabolism*
D013779:Tetrodotoxin; D012110:Reserpine; D010883:Piperoxan; D000109:Acetylcholine; D009638:Norepinephrine